| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Laparoscopy | 132 | 2018 | 782 | 13.790 |
Why?
|
| Nephrectomy | 78 | 2021 | 291 | 12.950 |
Why?
|
| Kidney Neoplasms | 51 | 2021 | 525 | 7.590 |
Why?
|
| Prostatectomy | 59 | 2016 | 475 | 7.430 |
Why?
|
| Robotics | 55 | 2018 | 270 | 7.010 |
Why?
|
| Kidney | 40 | 2021 | 1150 | 4.480 |
Why?
|
| Prostatic Neoplasms | 46 | 2016 | 1751 | 3.140 |
Why?
|
| Warm Ischemia | 13 | 2014 | 32 | 2.470 |
Why?
|
| Urologic Surgical Procedures | 15 | 2018 | 150 | 2.030 |
Why?
|
| Carcinoma, Renal Cell | 16 | 2016 | 333 | 2.000 |
Why?
|
| Middle Aged | 129 | 2021 | 26347 | 1.550 |
Why?
|
| Ureter | 18 | 2017 | 96 | 1.470 |
Why?
|
| Male | 158 | 2021 | 42967 | 1.450 |
Why?
|
| Urologic Neoplasms | 7 | 2017 | 74 | 1.430 |
Why?
|
| Erectile Dysfunction | 8 | 2010 | 76 | 1.370 |
Why?
|
| Kidney Diseases | 10 | 2012 | 321 | 1.360 |
Why?
|
| Ureteral Obstruction | 12 | 2011 | 69 | 1.340 |
Why?
|
| Postoperative Complications | 31 | 2017 | 2342 | 1.260 |
Why?
|
| Postoperative Hemorrhage | 4 | 2021 | 46 | 1.240 |
Why?
|
| Treatment Outcome | 66 | 2017 | 8379 | 1.240 |
Why?
|
| Aged | 91 | 2021 | 19424 | 1.240 |
Why?
|
| Suture Techniques | 8 | 2010 | 144 | 1.200 |
Why?
|
| Minimally Invasive Surgical Procedures | 10 | 2014 | 259 | 1.170 |
Why?
|
| Humans | 199 | 2021 | 90640 | 1.160 |
Why?
|
| Robotic Surgical Procedures | 7 | 2018 | 322 | 1.120 |
Why?
|
| Prostate | 10 | 2011 | 408 | 1.080 |
Why?
|
| Urinary Diversion | 5 | 2017 | 42 | 1.070 |
Why?
|
| Follow-Up Studies | 35 | 2021 | 3698 | 1.040 |
Why?
|
| Adrenalectomy | 3 | 2018 | 45 | 1.030 |
Why?
|
| Lymph Node Excision | 7 | 2017 | 222 | 1.000 |
Why?
|
| Female | 110 | 2021 | 46894 | 0.990 |
Why?
|
| Kidney Pelvis | 12 | 2011 | 50 | 0.960 |
Why?
|
| Intraoperative Complications | 9 | 2018 | 185 | 0.960 |
Why?
|
| Kidney Transplantation | 11 | 2008 | 860 | 0.930 |
Why?
|
| Hypothermia, Induced | 4 | 2010 | 83 | 0.930 |
Why?
|
| Angiomyolipoma | 3 | 2017 | 17 | 0.920 |
Why?
|
| Carcinoma, Transitional Cell | 7 | 2017 | 152 | 0.910 |
Why?
|
| Renal Artery | 4 | 2008 | 52 | 0.900 |
Why?
|
| Retrospective Studies | 51 | 2017 | 9330 | 0.880 |
Why?
|
| Creatinine | 9 | 2009 | 295 | 0.870 |
Why?
|
| Swine | 24 | 2013 | 593 | 0.870 |
Why?
|
| Cystectomy | 5 | 2017 | 106 | 0.850 |
Why?
|
| Embolization, Therapeutic | 2 | 2021 | 267 | 0.820 |
Why?
|
| Glomerular Filtration Rate | 11 | 2021 | 279 | 0.820 |
Why?
|
| Adult | 81 | 2016 | 26953 | 0.810 |
Why?
|
| Urinary Bladder | 10 | 2013 | 249 | 0.790 |
Why?
|
| Ice | 4 | 2010 | 11 | 0.780 |
Why?
|
| Kidney Function Tests | 9 | 2013 | 116 | 0.770 |
Why?
|
| Prospective Studies | 27 | 2017 | 4348 | 0.770 |
Why?
|
| Preoperative Care | 9 | 2013 | 400 | 0.750 |
Why?
|
| Renal Insufficiency | 2 | 2021 | 97 | 0.750 |
Why?
|
| Adrenal Gland Neoplasms | 2 | 2018 | 81 | 0.740 |
Why?
|
| Neoplasm Staging | 23 | 2016 | 2019 | 0.730 |
Why?
|
| Obesity | 5 | 2018 | 979 | 0.720 |
Why?
|
| Laparoscopes | 5 | 2008 | 15 | 0.720 |
Why?
|
| Time Factors | 23 | 2021 | 5366 | 0.710 |
Why?
|
| Kidney Tubules, Collecting | 3 | 2009 | 24 | 0.700 |
Why?
|
| Body Mass Index | 4 | 2014 | 776 | 0.670 |
Why?
|
| Seminal Vesicles | 6 | 2012 | 39 | 0.640 |
Why?
|
| Renal Veins | 3 | 2008 | 29 | 0.640 |
Why?
|
| Surgical Instruments | 4 | 2007 | 57 | 0.640 |
Why?
|
| Neoplasm Recurrence, Local | 7 | 2016 | 1362 | 0.640 |
Why?
|
| Sutures | 4 | 2009 | 59 | 0.630 |
Why?
|
| Polycystic Kidney, Autosomal Dominant | 5 | 2008 | 143 | 0.630 |
Why?
|
| Urology | 6 | 2008 | 121 | 0.610 |
Why?
|
| Ureteroscopy | 11 | 2007 | 38 | 0.590 |
Why?
|
| Urinary Incontinence | 6 | 2012 | 215 | 0.590 |
Why?
|
| Sus scrofa | 6 | 2013 | 51 | 0.580 |
Why?
|
| Nephrostomy, Percutaneous | 6 | 1998 | 32 | 0.570 |
Why?
|
| Reperfusion Injury | 2 | 2010 | 146 | 0.570 |
Why?
|
| Adenocarcinoma | 5 | 2009 | 1182 | 0.560 |
Why?
|
| Urinary Bladder, Neurogenic | 3 | 2011 | 26 | 0.560 |
Why?
|
| Tomography, X-Ray Computed | 13 | 2009 | 2705 | 0.550 |
Why?
|
| Aged, 80 and over | 32 | 2016 | 6816 | 0.550 |
Why?
|
| Electrocoagulation | 2 | 2008 | 23 | 0.540 |
Why?
|
| Catheter Ablation | 3 | 2008 | 256 | 0.530 |
Why?
|
| Urination Disorders | 5 | 2008 | 52 | 0.530 |
Why?
|
| Multivariate Analysis | 15 | 2017 | 982 | 0.510 |
Why?
|
| Ureteral Neoplasms | 3 | 2006 | 13 | 0.490 |
Why?
|
| General Surgery | 2 | 2008 | 244 | 0.480 |
Why?
|
| Logistic Models | 10 | 2021 | 1216 | 0.460 |
Why?
|
| Diagnostic Errors | 2 | 2013 | 160 | 0.460 |
Why?
|
| Anastomosis, Surgical | 7 | 2011 | 277 | 0.450 |
Why?
|
| Quality Improvement | 1 | 2017 | 459 | 0.430 |
Why?
|
| Prognosis | 11 | 2017 | 3813 | 0.430 |
Why?
|
| Retroperitoneal Neoplasms | 2 | 2006 | 44 | 0.420 |
Why?
|
| Models, Animal | 5 | 2010 | 278 | 0.400 |
Why?
|
| Risk Factors | 15 | 2021 | 5583 | 0.390 |
Why?
|
| Sural Nerve | 2 | 2008 | 19 | 0.380 |
Why?
|
| Lithotripsy | 6 | 2003 | 46 | 0.380 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2014 | 229 | 0.370 |
Why?
|
| Pneumoperitoneum, Artificial | 3 | 2007 | 7 | 0.360 |
Why?
|
| Ultrasonic Therapy | 2 | 2008 | 38 | 0.360 |
Why?
|
| Ileum | 4 | 2010 | 168 | 0.360 |
Why?
|
| Animals | 37 | 2013 | 27715 | 0.360 |
Why?
|
| Retroperitoneal Fibrosis | 2 | 2007 | 6 | 0.350 |
Why?
|
| Hemostatics | 2 | 2008 | 58 | 0.350 |
Why?
|
| Living Donors | 6 | 2007 | 339 | 0.350 |
Why?
|
| Postoperative Period | 6 | 2018 | 301 | 0.350 |
Why?
|
| Materials Testing | 2 | 2007 | 93 | 0.340 |
Why?
|
| Carcinoma | 1 | 2013 | 438 | 0.340 |
Why?
|
| Recovery of Function | 3 | 2010 | 305 | 0.340 |
Why?
|
| Age Factors | 7 | 2014 | 1871 | 0.330 |
Why?
|
| Prostate-Specific Antigen | 7 | 2013 | 342 | 0.330 |
Why?
|
| Risk Assessment | 11 | 2017 | 2338 | 0.330 |
Why?
|
| Proportional Hazards Models | 6 | 2021 | 841 | 0.330 |
Why?
|
| Postoperative Care | 7 | 2014 | 234 | 0.320 |
Why?
|
| Reoperation | 4 | 2009 | 609 | 0.310 |
Why?
|
| Overweight | 2 | 2008 | 118 | 0.310 |
Why?
|
| Hemostasis, Surgical | 1 | 2008 | 25 | 0.300 |
Why?
|
| Analysis of Variance | 5 | 2014 | 898 | 0.300 |
Why?
|
| Ultrasonography, Interventional | 1 | 2008 | 126 | 0.300 |
Why?
|
| Adrenocortical Adenoma | 1 | 2007 | 2 | 0.300 |
Why?
|
| Occupational Diseases | 2 | 2008 | 55 | 0.300 |
Why?
|
| Neuromuscular Diseases | 1 | 2008 | 31 | 0.300 |
Why?
|
| Disease Models, Animal | 8 | 2012 | 2409 | 0.300 |
Why?
|
| Fellowships and Scholarships | 2 | 2007 | 129 | 0.290 |
Why?
|
| Waxes | 1 | 2007 | 1 | 0.290 |
Why?
|
| Palmitates | 1 | 2007 | 16 | 0.290 |
Why?
|
| Arthritis | 1 | 2008 | 49 | 0.290 |
Why?
|
| Adrenal Cortex Neoplasms | 1 | 2007 | 18 | 0.290 |
Why?
|
| Medical Illustration | 2 | 2007 | 16 | 0.290 |
Why?
|
| Biopsy | 9 | 2016 | 1192 | 0.290 |
Why?
|
| Pneumothorax | 1 | 2007 | 53 | 0.280 |
Why?
|
| Kidney Calculi | 6 | 2000 | 343 | 0.280 |
Why?
|
| Intestines | 1 | 2010 | 416 | 0.280 |
Why?
|
| Polycystic Kidney Diseases | 2 | 2004 | 20 | 0.280 |
Why?
|
| Stents | 9 | 2007 | 416 | 0.280 |
Why?
|
| Aneurysm, False | 1 | 2007 | 55 | 0.280 |
Why?
|
| Ischemic Preconditioning | 1 | 2007 | 37 | 0.280 |
Why?
|
| Intraoperative Period | 4 | 2008 | 91 | 0.270 |
Why?
|
| Carbon Dioxide | 1 | 2007 | 205 | 0.270 |
Why?
|
| Tensile Strength | 1 | 2007 | 83 | 0.270 |
Why?
|
| Papilloma, Inverted | 1 | 2006 | 6 | 0.270 |
Why?
|
| Surveys and Questionnaires | 10 | 2010 | 2670 | 0.260 |
Why?
|
| Pituitary ACTH Hypersecretion | 1 | 2006 | 11 | 0.260 |
Why?
|
| Feasibility Studies | 7 | 2010 | 791 | 0.260 |
Why?
|
| Cushing Syndrome | 1 | 2006 | 24 | 0.260 |
Why?
|
| Liposarcoma | 1 | 2006 | 12 | 0.260 |
Why?
|
| Retroperitoneal Space | 1 | 2006 | 39 | 0.260 |
Why?
|
| Equipment Design | 8 | 2012 | 423 | 0.260 |
Why?
|
| Tumor Burden | 3 | 2017 | 316 | 0.250 |
Why?
|
| Learning | 2 | 2015 | 287 | 0.250 |
Why?
|
| Predictive Value of Tests | 10 | 2016 | 1747 | 0.250 |
Why?
|
| Biopsy, Needle | 7 | 2013 | 233 | 0.250 |
Why?
|
| Demography | 4 | 2010 | 184 | 0.240 |
Why?
|
| Urography | 13 | 2009 | 45 | 0.240 |
Why?
|
| Blood Specimen Collection | 1 | 2005 | 28 | 0.240 |
Why?
|
| Cystoscopy | 3 | 2008 | 38 | 0.240 |
Why?
|
| Kidney Calices | 3 | 1999 | 5 | 0.240 |
Why?
|
| Tissue Donors | 2 | 2008 | 511 | 0.240 |
Why?
|
| Diagnosis, Differential | 6 | 2011 | 1608 | 0.240 |
Why?
|
| Surgical Stapling | 1 | 2004 | 17 | 0.240 |
Why?
|
| Argon | 1 | 2004 | 10 | 0.240 |
Why?
|
| Catheterization | 3 | 2005 | 239 | 0.240 |
Why?
|
| Regression Analysis | 3 | 2013 | 591 | 0.230 |
Why?
|
| Nomograms | 3 | 2009 | 32 | 0.230 |
Why?
|
| Sensitivity and Specificity | 5 | 2008 | 2019 | 0.230 |
Why?
|
| Catheters, Indwelling | 1 | 2005 | 114 | 0.230 |
Why?
|
| Swine, Miniature | 11 | 2003 | 50 | 0.230 |
Why?
|
| Adipose Tissue | 1 | 2006 | 263 | 0.210 |
Why?
|
| Cystostomy | 3 | 2011 | 15 | 0.210 |
Why?
|
| Physicians | 2 | 2009 | 690 | 0.210 |
Why?
|
| Probability | 5 | 2010 | 357 | 0.210 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2004 | 565 | 0.210 |
Why?
|
| Blood Loss, Surgical | 4 | 2008 | 117 | 0.210 |
Why?
|
| Case-Control Studies | 3 | 2021 | 1873 | 0.200 |
Why?
|
| Laser Therapy | 2 | 2012 | 149 | 0.200 |
Why?
|
| Cold Ischemia | 2 | 2014 | 19 | 0.200 |
Why?
|
| Urinary Calculi | 2 | 1999 | 46 | 0.200 |
Why?
|
| Neoplasms, Second Primary | 1 | 2004 | 240 | 0.190 |
Why?
|
| Cohort Studies | 8 | 2013 | 2891 | 0.190 |
Why?
|
| Iatrogenic Disease | 1 | 2021 | 71 | 0.180 |
Why?
|
| Endoscopy | 4 | 1998 | 353 | 0.180 |
Why?
|
| Neoplasm Invasiveness | 7 | 2016 | 570 | 0.180 |
Why?
|
| Endoscopy, Digestive System | 1 | 2001 | 69 | 0.180 |
Why?
|
| Appendix | 2 | 2011 | 31 | 0.180 |
Why?
|
| Neoplasm Grading | 4 | 2016 | 376 | 0.180 |
Why?
|
| Hyperaldosteronism | 1 | 2000 | 12 | 0.180 |
Why?
|
| Urinary Reservoirs, Continent | 3 | 2011 | 14 | 0.180 |
Why?
|
| Pregnancy Complications, Neoplastic | 1 | 2000 | 28 | 0.170 |
Why?
|
| Patient Positioning | 2 | 2018 | 65 | 0.170 |
Why?
|
| Anuria | 1 | 1999 | 6 | 0.170 |
Why?
|
| Neoplasm Metastasis | 2 | 2018 | 1066 | 0.170 |
Why?
|
| Immunosuppressive Agents | 1 | 2004 | 984 | 0.160 |
Why?
|
| Disease-Free Survival | 5 | 2016 | 1170 | 0.160 |
Why?
|
| Margins of Excision | 2 | 2017 | 42 | 0.160 |
Why?
|
| Organ Size | 4 | 2010 | 375 | 0.160 |
Why?
|
| Education, Medical, Graduate | 2 | 2009 | 406 | 0.160 |
Why?
|
| Constriction | 2 | 2009 | 27 | 0.160 |
Why?
|
| Absorbable Implants | 1 | 1999 | 37 | 0.160 |
Why?
|
| Random Allocation | 3 | 2008 | 327 | 0.150 |
Why?
|
| Diverticulum | 1 | 1998 | 45 | 0.150 |
Why?
|
| Antibodies, Monoclonal | 1 | 2004 | 1397 | 0.150 |
Why?
|
| Kidney Failure, Chronic | 3 | 2010 | 417 | 0.150 |
Why?
|
| Urologic Diseases | 2 | 2017 | 44 | 0.150 |
Why?
|
| Adenoma | 1 | 2000 | 250 | 0.150 |
Why?
|
| Preoperative Period | 1 | 2018 | 94 | 0.150 |
Why?
|
| Pheochromocytoma | 1 | 2018 | 49 | 0.150 |
Why?
|
| Nephroureterectomy | 1 | 2017 | 1 | 0.140 |
Why?
|
| Extracellular Matrix | 1 | 1999 | 248 | 0.140 |
Why?
|
| Chemotherapy, Adjuvant | 3 | 2008 | 478 | 0.140 |
Why?
|
| Drainage | 2 | 2014 | 166 | 0.140 |
Why?
|
| Intraoperative Care | 2 | 2010 | 85 | 0.140 |
Why?
|
| Urinary Bladder Neoplasms | 3 | 2008 | 367 | 0.140 |
Why?
|
| Health Plan Implementation | 1 | 2017 | 56 | 0.140 |
Why?
|
| Ureteral Calculi | 2 | 2010 | 10 | 0.140 |
Why?
|
| Child | 6 | 2017 | 7219 | 0.140 |
Why?
|
| Perioperative Care | 4 | 2016 | 171 | 0.140 |
Why?
|
| Tertiary Care Centers | 1 | 2017 | 112 | 0.140 |
Why?
|
| Radiography, Abdominal | 2 | 2007 | 70 | 0.130 |
Why?
|
| Rhabdomyolysis | 2 | 2015 | 28 | 0.130 |
Why?
|
| Polyglactin 910 | 2 | 2007 | 5 | 0.130 |
Why?
|
| Incidence | 5 | 2013 | 1594 | 0.130 |
Why?
|
| Survival Analysis | 3 | 2017 | 1500 | 0.130 |
Why?
|
| Survival Rate | 5 | 2015 | 1895 | 0.130 |
Why?
|
| Operative Time | 2 | 2013 | 151 | 0.130 |
Why?
|
| Pelvis | 3 | 2015 | 96 | 0.130 |
Why?
|
| Cadaver | 2 | 2008 | 186 | 0.130 |
Why?
|
| Reference Values | 2 | 2007 | 662 | 0.130 |
Why?
|
| Lymphatic Metastasis | 4 | 2015 | 498 | 0.130 |
Why?
|
| Rectal Diseases | 1 | 2015 | 23 | 0.130 |
Why?
|
| Cornea | 1 | 1996 | 70 | 0.120 |
Why?
|
| Young Adult | 7 | 2016 | 6426 | 0.120 |
Why?
|
| Intestinal Perforation | 1 | 2015 | 36 | 0.120 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2010 | 3486 | 0.120 |
Why?
|
| Aspirin | 1 | 2016 | 162 | 0.120 |
Why?
|
| Neoplasm, Residual | 3 | 2012 | 185 | 0.120 |
Why?
|
| Acute Disease | 2 | 2007 | 854 | 0.120 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2016 | 150 | 0.120 |
Why?
|
| Equipment Failure | 3 | 2015 | 123 | 0.120 |
Why?
|
| Blood Vessels | 2 | 2015 | 94 | 0.120 |
Why?
|
| In Vitro Techniques | 3 | 2010 | 997 | 0.120 |
Why?
|
| Models, Biological | 2 | 2012 | 1770 | 0.120 |
Why?
|
| Ablation Techniques | 2 | 2011 | 38 | 0.110 |
Why?
|
| Adolescent | 7 | 2016 | 9354 | 0.110 |
Why?
|
| Urinary Catheters | 1 | 2014 | 6 | 0.110 |
Why?
|
| Nephrons | 2 | 2012 | 17 | 0.110 |
Why?
|
| Urodynamics | 4 | 2008 | 123 | 0.110 |
Why?
|
| Peritoneal Diseases | 1 | 2013 | 16 | 0.110 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2016 | 854 | 0.110 |
Why?
|
| Length of Stay | 4 | 2013 | 757 | 0.110 |
Why?
|
| Neoplasm Seeding | 4 | 2008 | 16 | 0.110 |
Why?
|
| Urinary Catheterization | 1 | 2014 | 36 | 0.110 |
Why?
|
| Biopsy, Large-Core Needle | 1 | 2013 | 15 | 0.110 |
Why?
|
| Immunohistochemistry | 3 | 2013 | 1806 | 0.110 |
Why?
|
| Critical Pathways | 1 | 2013 | 37 | 0.110 |
Why?
|
| Lasers, Gas | 1 | 2012 | 4 | 0.100 |
Why?
|
| Linear Models | 2 | 2014 | 427 | 0.100 |
Why?
|
| Ureterostomy | 2 | 2006 | 3 | 0.100 |
Why?
|
| Specimen Handling | 1 | 2013 | 103 | 0.100 |
Why?
|
| Likelihood Functions | 1 | 2013 | 252 | 0.100 |
Why?
|
| Liver Transplantation | 1 | 2000 | 1179 | 0.100 |
Why?
|
| Clinical Competence | 4 | 2009 | 796 | 0.100 |
Why?
|
| Quality of Life | 4 | 2008 | 1693 | 0.100 |
Why?
|
| Device Removal | 1 | 2014 | 169 | 0.100 |
Why?
|
| Risk | 2 | 2010 | 656 | 0.100 |
Why?
|
| Kidney Diseases, Cystic | 2 | 2004 | 22 | 0.100 |
Why?
|
| Testicular Neoplasms | 1 | 2013 | 114 | 0.090 |
Why?
|
| Mathematics | 2 | 2010 | 191 | 0.090 |
Why?
|
| Ostomy | 1 | 2011 | 15 | 0.090 |
Why?
|
| Surgery, Computer-Assisted | 2 | 2009 | 99 | 0.090 |
Why?
|
| Radiography | 5 | 2006 | 809 | 0.090 |
Why?
|
| Spinal Dysraphism | 1 | 2010 | 19 | 0.090 |
Why?
|
| Comorbidity | 1 | 2014 | 955 | 0.090 |
Why?
|
| Frozen Sections | 1 | 2010 | 50 | 0.090 |
Why?
|
| Hypertension, Renal | 2 | 2008 | 19 | 0.090 |
Why?
|
| Suspensions | 1 | 2010 | 6 | 0.090 |
Why?
|
| Patient Discharge | 1 | 2013 | 328 | 0.090 |
Why?
|
| Saline Solution, Hypertonic | 1 | 2010 | 24 | 0.090 |
Why?
|
| Hospitals, University | 4 | 2003 | 196 | 0.090 |
Why?
|
| Urine | 2 | 2002 | 94 | 0.090 |
Why?
|
| Body Temperature | 1 | 2010 | 126 | 0.080 |
Why?
|
| Life Expectancy | 1 | 2010 | 88 | 0.080 |
Why?
|
| Particle Size | 1 | 2010 | 127 | 0.080 |
Why?
|
| Blood Vessel Prosthesis Implantation | 2 | 2009 | 228 | 0.080 |
Why?
|
| Weight Loss | 1 | 2011 | 235 | 0.080 |
Why?
|
| Credentialing | 1 | 2009 | 14 | 0.080 |
Why?
|
| Lymphocele | 1 | 2009 | 6 | 0.080 |
Why?
|
| Wolffian Ducts | 1 | 2009 | 7 | 0.080 |
Why?
|
| Femoral Artery | 1 | 2009 | 84 | 0.080 |
Why?
|
| Prostatic Hyperplasia | 1 | 2010 | 90 | 0.080 |
Why?
|
| Ossification, Heterotopic | 1 | 2009 | 34 | 0.080 |
Why?
|
| Therapeutic Irrigation | 2 | 2010 | 60 | 0.080 |
Why?
|
| Databases as Topic | 1 | 2009 | 94 | 0.080 |
Why?
|
| Equipment Safety | 1 | 2008 | 33 | 0.080 |
Why?
|
| Ligation | 2 | 2009 | 53 | 0.080 |
Why?
|
| Drug Combinations | 2 | 2007 | 204 | 0.080 |
Why?
|
| Fasciotomy | 2 | 2009 | 17 | 0.080 |
Why?
|
| Posture | 2 | 1999 | 125 | 0.080 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2009 | 75 | 0.080 |
Why?
|
| Peripheral Nerve Injuries | 2 | 2015 | 14 | 0.070 |
Why?
|
| Lymph Nodes | 2 | 2010 | 553 | 0.070 |
Why?
|
| Incidental Findings | 2 | 2009 | 99 | 0.070 |
Why?
|
| Hemostasis, Endoscopic | 1 | 2008 | 16 | 0.070 |
Why?
|
| Urinary Bladder Neck Obstruction | 1 | 2008 | 21 | 0.070 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2009 | 120 | 0.070 |
Why?
|
| Remission, Spontaneous | 1 | 2007 | 52 | 0.070 |
Why?
|
| Aorta | 1 | 2009 | 291 | 0.070 |
Why?
|
| Punctures | 1 | 2007 | 30 | 0.070 |
Why?
|
| Sexual Dysfunction, Physiological | 1 | 2008 | 69 | 0.070 |
Why?
|
| Intestine, Small | 2 | 2000 | 299 | 0.070 |
Why?
|
| Chronic Disease | 2 | 2010 | 959 | 0.070 |
Why?
|
| Hypertension | 3 | 2003 | 746 | 0.070 |
Why?
|
| History, 21st Century | 1 | 2008 | 185 | 0.070 |
Why?
|
| Polypropylenes | 1 | 2007 | 23 | 0.070 |
Why?
|
| Radioisotope Renography | 1 | 2007 | 7 | 0.070 |
Why?
|
| Nephrology | 1 | 2007 | 42 | 0.070 |
Why?
|
| Cryosurgery | 2 | 2004 | 58 | 0.070 |
Why?
|
| History, 20th Century | 1 | 2008 | 315 | 0.070 |
Why?
|
| Multicenter Studies as Topic | 1 | 2007 | 168 | 0.070 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2008 | 89 | 0.070 |
Why?
|
| Vascular Surgical Procedures | 1 | 2008 | 150 | 0.070 |
Why?
|
| Glucocorticoids | 2 | 2007 | 359 | 0.070 |
Why?
|
| Child, Preschool | 2 | 2011 | 3767 | 0.070 |
Why?
|
| Health Care Surveys | 1 | 2007 | 279 | 0.070 |
Why?
|
| Intestinal Mucosa | 2 | 2002 | 807 | 0.070 |
Why?
|
| Transplantation, Autologous | 2 | 2004 | 351 | 0.060 |
Why?
|
| Hospitals | 1 | 2008 | 309 | 0.060 |
Why?
|
| Radiography, Thoracic | 1 | 2007 | 327 | 0.060 |
Why?
|
| Traction | 1 | 2005 | 5 | 0.060 |
Why?
|
| Surgical Staplers | 1 | 2004 | 11 | 0.060 |
Why?
|
| Jugular Veins | 1 | 2005 | 74 | 0.060 |
Why?
|
| Equipment and Supplies | 1 | 2004 | 28 | 0.060 |
Why?
|
| Thromboembolism | 1 | 2005 | 124 | 0.060 |
Why?
|
| Arteriovenous Fistula | 1 | 2004 | 53 | 0.060 |
Why?
|
| Urology Department, Hospital | 1 | 2003 | 1 | 0.060 |
Why?
|
| Urinary Tract Infections | 2 | 2001 | 76 | 0.060 |
Why?
|
| Androgens | 1 | 2004 | 175 | 0.060 |
Why?
|
| ROC Curve | 3 | 2012 | 781 | 0.060 |
Why?
|
| Pilot Projects | 1 | 2006 | 879 | 0.060 |
Why?
|
| Disease Progression | 1 | 2008 | 1486 | 0.050 |
Why?
|
| Lymphoma, B-Cell | 1 | 2004 | 110 | 0.050 |
Why?
|
| Pain | 2 | 2003 | 399 | 0.050 |
Why?
|
| Diabetes Complications | 1 | 2004 | 172 | 0.050 |
Why?
|
| Coronary Disease | 1 | 2004 | 261 | 0.050 |
Why?
|
| Renal Circulation | 1 | 2003 | 48 | 0.050 |
Why?
|
| Lithotripsy, Laser | 2 | 1999 | 3 | 0.050 |
Why?
|
| Ohio | 1 | 2002 | 41 | 0.050 |
Why?
|
| Tomography, Spiral Computed | 1 | 2002 | 77 | 0.050 |
Why?
|
| Hemostasis | 1 | 2002 | 20 | 0.050 |
Why?
|
| Stress, Physiological | 1 | 2004 | 234 | 0.050 |
Why?
|
| Computer-Assisted Instruction | 1 | 2002 | 44 | 0.050 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2002 | 79 | 0.050 |
Why?
|
| Models, Anatomic | 1 | 2002 | 92 | 0.050 |
Why?
|
| Genital Diseases, Male | 1 | 2001 | 9 | 0.050 |
Why?
|
| Hematuria | 2 | 2000 | 50 | 0.050 |
Why?
|
| Odds Ratio | 2 | 2017 | 680 | 0.050 |
Why?
|
| Hydronephrosis | 1 | 2001 | 33 | 0.050 |
Why?
|
| Ultrasonography | 5 | 2004 | 722 | 0.050 |
Why?
|
| Education, Medical, Continuing | 3 | 2009 | 106 | 0.050 |
Why?
|
| Sepsis | 1 | 2005 | 330 | 0.050 |
Why?
|
| Ureteroscopes | 1 | 2000 | 3 | 0.050 |
Why?
|
| User-Computer Interface | 1 | 2002 | 187 | 0.050 |
Why?
|
| Confidence Intervals | 2 | 2013 | 220 | 0.050 |
Why?
|
| Biocompatible Materials | 2 | 1999 | 198 | 0.040 |
Why?
|
| Cysts | 1 | 2001 | 106 | 0.040 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2000 | 70 | 0.040 |
Why?
|
| Pyelonephritis, Xanthogranulomatous | 1 | 1999 | 2 | 0.040 |
Why?
|
| Replantation | 1 | 2000 | 36 | 0.040 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 2000 | 110 | 0.040 |
Why?
|
| Dilatation | 1 | 1999 | 48 | 0.040 |
Why?
|
| Silicones | 1 | 1999 | 21 | 0.040 |
Why?
|
| Biomarkers, Tumor | 1 | 2007 | 1549 | 0.040 |
Why?
|
| Algorithms | 1 | 2007 | 1919 | 0.040 |
Why?
|
| Urothelium | 1 | 1999 | 63 | 0.040 |
Why?
|
| Tuberculosis, Renal | 1 | 1998 | 1 | 0.040 |
Why?
|
| Graft Rejection | 1 | 2004 | 1084 | 0.040 |
Why?
|
| Urinary Bladder Diseases | 1 | 1998 | 41 | 0.040 |
Why?
|
| Digestive System Surgical Procedures | 1 | 1999 | 131 | 0.040 |
Why?
|
| Vesico-Ureteral Reflux | 1 | 1998 | 28 | 0.040 |
Why?
|
| Treatment Failure | 1 | 1998 | 282 | 0.040 |
Why?
|
| Curriculum | 1 | 2002 | 574 | 0.040 |
Why?
|
| Prostheses and Implants | 1 | 1998 | 125 | 0.040 |
Why?
|
| Models, Statistical | 2 | 2012 | 576 | 0.030 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 1998 | 160 | 0.030 |
Why?
|
| Health Care Rationing | 1 | 2017 | 83 | 0.030 |
Why?
|
| Radio Waves | 1 | 1996 | 15 | 0.030 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 1996 | 26 | 0.030 |
Why?
|
| Anesthesia | 2 | 2009 | 168 | 0.030 |
Why?
|
| Immersion | 1 | 1996 | 21 | 0.030 |
Why?
|
| Corneal Injuries | 1 | 1996 | 10 | 0.030 |
Why?
|
| Denervation | 2 | 2008 | 25 | 0.030 |
Why?
|
| Mycobacterium tuberculosis | 1 | 1998 | 198 | 0.030 |
Why?
|
| Hyperthermia, Induced | 1 | 1996 | 73 | 0.030 |
Why?
|
| Phentolamine | 1 | 1995 | 8 | 0.030 |
Why?
|
| Papaverine | 1 | 1995 | 5 | 0.030 |
Why?
|
| Alprostadil | 1 | 1995 | 25 | 0.030 |
Why?
|
| Incisional Hernia | 1 | 2015 | 17 | 0.030 |
Why?
|
| Pain, Postoperative | 2 | 2014 | 258 | 0.030 |
Why?
|
| Blood Transfusion | 1 | 2016 | 170 | 0.030 |
Why?
|
| Cattle | 1 | 1996 | 379 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2001 | 1259 | 0.030 |
Why?
|
| Morbidity | 1 | 2015 | 151 | 0.030 |
Why?
|
| Internship and Residency | 2 | 2017 | 1068 | 0.030 |
Why?
|
| Water | 1 | 1996 | 287 | 0.030 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2013 | 604 | 0.030 |
Why?
|
| Patient Selection | 2 | 2013 | 682 | 0.030 |
Why?
|
| Tissue Adhesions | 1 | 2013 | 51 | 0.030 |
Why?
|
| Indiana | 2 | 2003 | 14 | 0.030 |
Why?
|
| Pliability | 1 | 2012 | 5 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2016 | 875 | 0.030 |
Why?
|
| Pregnancy | 1 | 2000 | 3070 | 0.030 |
Why?
|
| Infant | 1 | 1999 | 3184 | 0.030 |
Why?
|
| Rats | 2 | 2009 | 4061 | 0.020 |
Why?
|
| Chicago | 1 | 2016 | 1441 | 0.020 |
Why?
|
| United States | 2 | 2015 | 7142 | 0.020 |
Why?
|
| Sex Factors | 1 | 2014 | 1074 | 0.020 |
Why?
|
| Epidemiologic Methods | 1 | 2010 | 60 | 0.020 |
Why?
|
| Atherectomy | 1 | 2010 | 4 | 0.020 |
Why?
|
| Radionuclide Imaging | 2 | 2003 | 222 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2010 | 122 | 0.020 |
Why?
|
| Cause of Death | 1 | 2011 | 270 | 0.020 |
Why?
|
| Decision Support Techniques | 1 | 2012 | 170 | 0.020 |
Why?
|
| Vas Deferens | 1 | 2009 | 8 | 0.020 |
Why?
|
| Aortography | 1 | 2009 | 65 | 0.020 |
Why?
|
| Calibration | 1 | 2008 | 104 | 0.020 |
Why?
|
| Rats, Mutant Strains | 1 | 2008 | 23 | 0.020 |
Why?
|
| Wound Healing | 2 | 2002 | 365 | 0.020 |
Why?
|
| Retreatment | 2 | 1998 | 107 | 0.020 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2010 | 300 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2008 | 338 | 0.020 |
Why?
|
| Renin-Angiotensin System | 1 | 2008 | 80 | 0.020 |
Why?
|
| Delayed Graft Function | 1 | 2007 | 15 | 0.020 |
Why?
|
| Heterozygote | 1 | 2008 | 373 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2008 | 355 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2007 | 360 | 0.020 |
Why?
|
| Rabbits | 2 | 1998 | 641 | 0.020 |
Why?
|
| Palpation | 1 | 2005 | 18 | 0.020 |
Why?
|
| Cardiovascular Diseases | 1 | 2011 | 726 | 0.010 |
Why?
|
| Hemorrhage | 1 | 2007 | 290 | 0.010 |
Why?
|
| Recurrence | 1 | 2008 | 1162 | 0.010 |
Why?
|
| Missouri | 1 | 2003 | 18 | 0.010 |
Why?
|
| Ischemia | 1 | 2006 | 254 | 0.010 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2004 | 291 | 0.010 |
Why?
|
| Salvage Therapy | 1 | 2004 | 233 | 0.010 |
Why?
|
| Renal Plasma Flow | 1 | 2003 | 1 | 0.010 |
Why?
|
| p-Aminohippuric Acid | 1 | 2003 | 4 | 0.010 |
Why?
|
| Inulin | 1 | 2003 | 17 | 0.010 |
Why?
|
| Awards and Prizes | 1 | 2003 | 36 | 0.010 |
Why?
|
| Graft Survival | 1 | 2007 | 913 | 0.010 |
Why?
|
| Metabolic Clearance Rate | 1 | 2003 | 120 | 0.010 |
Why?
|
| Sympathetic Nervous System | 1 | 2003 | 98 | 0.010 |
Why?
|
| Norepinephrine | 1 | 2003 | 172 | 0.010 |
Why?
|
| Analgesics | 1 | 2003 | 119 | 0.010 |
Why?
|
| Kidney Glomerulus | 1 | 2003 | 122 | 0.010 |
Why?
|
| Emergencies | 1 | 2002 | 122 | 0.010 |
Why?
|
| Models, Structural | 1 | 2000 | 58 | 0.010 |
Why?
|
| Biodegradation, Environmental | 1 | 2000 | 18 | 0.010 |
Why?
|
| Lighting | 1 | 2000 | 33 | 0.010 |
Why?
|
| Shoulder Pain | 1 | 2000 | 7 | 0.010 |
Why?
|
| Back Injuries | 1 | 2000 | 6 | 0.010 |
Why?
|
| Sprains and Strains | 1 | 2000 | 12 | 0.010 |
Why?
|
| Abdominal Muscles | 1 | 2000 | 19 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 2000 | 270 | 0.010 |
Why?
|
| Neuralgia | 1 | 2000 | 31 | 0.010 |
Why?
|
| Pressure | 1 | 2000 | 167 | 0.010 |
Why?
|
| Hospital Mortality | 1 | 2002 | 426 | 0.010 |
Why?
|
| Single-Blind Method | 1 | 2000 | 152 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2003 | 1709 | 0.010 |
Why?
|
| Decision Trees | 1 | 1999 | 61 | 0.010 |
Why?
|
| Congenital Abnormalities | 1 | 1999 | 64 | 0.010 |
Why?
|
| Health Surveys | 1 | 2000 | 239 | 0.010 |
Why?
|
| Hemodynamics | 1 | 2003 | 739 | 0.010 |
Why?
|
| Fiber Optic Technology | 1 | 1999 | 36 | 0.010 |
Why?
|
| Secondary Prevention | 1 | 1999 | 162 | 0.010 |
Why?
|
| Decision Making | 1 | 2004 | 672 | 0.010 |
Why?
|
| Artificial Organs | 1 | 1998 | 4 | 0.010 |
Why?
|
| Antitubercular Agents | 1 | 1998 | 54 | 0.010 |
Why?
|
| Triamcinolone | 1 | 1998 | 19 | 0.010 |
Why?
|
| Dissection | 1 | 1998 | 44 | 0.010 |
Why?
|
| Immunotherapy | 1 | 2003 | 702 | 0.010 |
Why?
|
| Omentum | 1 | 1998 | 74 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2003 | 1882 | 0.010 |
Why?
|
| Renal Dialysis | 1 | 2000 | 339 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2002 | 1738 | 0.010 |
Why?
|
| Remission Induction | 1 | 1998 | 745 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 1998 | 795 | 0.010 |
Why?
|
| Necrosis | 1 | 1996 | 211 | 0.010 |
Why?
|
| Impotence, Vasculogenic | 1 | 1995 | 3 | 0.010 |
Why?
|
| Neoplasm Transplantation | 1 | 1996 | 397 | 0.010 |
Why?
|
| Penile Erection | 1 | 1995 | 22 | 0.010 |
Why?
|
| Surgical Flaps | 1 | 1998 | 254 | 0.010 |
Why?
|
| Injections | 1 | 1995 | 116 | 0.010 |
Why?
|
| Penis | 1 | 1995 | 61 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 1995 | 1727 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2003 | 2370 | 0.010 |
Why?
|